CRL - Charles River Axovia to collaborate on gene therapy development
2024-04-09 10:48:26 ET
More on Charles River Laboratories
- Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
- Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript
- Charles River brokers gene therapy manufacturing pact with Navega Therapeutics
- DURECT and Charles River enter agreement for alzet in U.S., Canada
- Seeking Alpha’s Quant Rating on Charles River Laboratories